Healing Touch and Relaxation Therapies in Cervical Cancer Patients
Study Details
Study Description
Brief Summary
The purpose of this study is to evaluate the effects of healing touch and relaxation therapy on cervical cancer patients undergoing chemotherapy and radiation treatment.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 2 |
Detailed Description
The side effects of chemotherapy and radiation treatment are often severe and can have devastating effects on the mental and physical well-being of cancer patients. This study will determine whether healing touch and relaxation therapy are effective in minimizing the side effects of chemotherapy and radiation treatment in cervical cancer patients.
Participants in this study will receive weekly chemotherapy and daily radiation treatments for 6 weeks. Participants will be randomly assigned to receive either standard care (SC), SC plus relaxation therapy, or SC plus healing touch therapy. The relaxation therapy consists of progressive muscle relaxation and guided imagery. The healing touch therapy involves an energy-based modality in which health care practitioners stimulate the energy fields surrounding the patient. A physician-completed assessment and measures of immune function will be used to assess the well-being and overall quality of life of participants.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Healing Touch Healing Touch Therapy |
Behavioral: Healing Touch Therapy
|
Active Comparator: Relaxation Therapy Relaxation Therapy |
Behavioral: Relaxation Therapy
|
Placebo Comparator: Standard Care Standard Care |
Behavioral: Standard Care
Standard Care
|
Outcome Measures
Primary Outcome Measures
- natural killer cell cytotoxicity [Baseline to week 6]
- T-cell counts [Baseline to week 6]
- side effects [Baseline to week 6]
Secondary Outcome Measures
- distress [Baseline to week 6]
- WBC and RBC [Baseline to week 6]
- days of treatment delay [Baseline to week 6]
- salivary cortisol [Baseline to post-treatment]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Stage Ib1-IVa cervical cancer
-
Treatment with concurrent chemotherapy and radiation at the University of Iowa Hospitals and Clinics
Exclusion Criteria:
-
Immunosuppressive disorders
-
Use of immunosuppressive medications
-
Transplant recipient
-
Metastatic or recurrent cervical cancer
-
History of any other type of cancer
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Iowa Hospital and Clinics | Iowa City | Iowa | United States | 52242 |
Sponsors and Collaborators
- National Center for Complementary and Integrative Health (NCCIH)
Investigators
- Principal Investigator: Susan K Lutgendorf, MD, University of Iowa
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- P20AT000756-01
- NCT00065091